Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

International journal of hematology·2026
Same author

Author Correction: Regulation of urea cycle by reversible high-stoichiometry lysine succinylation.

Nature metabolism·2026
Same author

Exceptional Longevity Modifying Allele APOE2 Promotes DNA Signaling Pathways Resisting Cellular Senescence in Human Neurons.

Aging cell·2026
Same author

Ketone ester supplementation in aged mice reduces activation of B cell subsets.

bioRxiv : the preprint server for biology·2026
Same author

Replacement-Based Ageing Interventions for Systemic Rejuvenation: Shaping Longevity Science and Clinical Directions.

Aging cell·2026
Same author

p21<sup>+</sup>TREM2<sup>+</sup> senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease.

Nature aging·2026

Related Experiment Video

Updated: May 24, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

HIV latency: experimental systems and molecular models.

Shweta Hakre1, Leonard Chavez, Kotaro Shirakawa

  • 1Gladstone Institute of Virology and Immunology, University of California, San Francisco, CA 94941, USA.

FEMS Microbiology Reviews
|March 1, 2012
PubMed
Summary

Highly active antiretroviral therapy (HAART) controls HIV but does not eliminate it. Research explores epigenetic mechanisms and histone deacetylase (HDAC) inhibitors to reactivate latent HIV, potentially leading to virus eradication.

More Related Videos

Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

A Rat Model of EcoHIV Brain Infection
08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Related Experiment Videos

Last Updated: May 24, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

A Rat Model of EcoHIV Brain Infection
08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Area of Science:

  • Virology
  • Immunology
  • Epigenetics

Background:

  • Highly active antiretroviral therapy (HAART) significantly improves survival for individuals with HIV.
  • HAART does not eradicate the virus, necessitating lifelong treatment.
  • Latent HIV reservoirs in resting T cells can reactivate upon T-cell activation, persisting despite HAART.

Purpose of the Study:

  • To review recent advances in understanding the molecular mechanisms of HIV latency.
  • To examine experimental models used to study HIV latency.
  • To discuss the potential of epigenetic modifiers, like HDAC inhibitors, in HIV eradication strategies.

Main Methods:

  • Review of current literature on HIV latency.
  • Focus on epigenetic mechanisms controlling HIV transcription, including chromatin modifications.
  • Analysis of experimental models for studying latent HIV reservoirs.

Main Results:

  • Epigenetic modifications, particularly to chromatin, play a crucial role in regulating HIV transcription and maintaining latency.
  • Histone deacetylase (HDAC) inhibitors show promise in reactivating transcriptionally silent HIV.
  • Small molecule inhibitors targeting epigenetic regulators are being investigated for their therapeutic potential.

Conclusions:

  • Understanding epigenetic regulation is key to targeting latent HIV reservoirs.
  • HDAC inhibitors offer a potential strategy to "shock and kill" latently infected cells.
  • Further research into epigenetic therapies could lead to strategies for HIV eradication.